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Abstract
Pathogens of the Mycobacterium tuberculosis complex (MTBC) are considered to be monomorphic, with little gene content vari-
ation between strains. Nevertheless, several genotypic and phenotypic factors separate strains of the different MTBC lineages 
(L), especially L5 and L6 (traditionally termed Mycobacterium africanum) strains, from each other. However, this genome vari-
ability and gene content, especially of L5 strains, has not been fully explored and may be important for pathobiology and current 
approaches for genomic analysis of MTBC strains, including transmission studies. By comparing the genomes of 355 L5 clinical 
strains (including 3 complete genomes and 352 Illumina whole- genome sequenced isolates) to each other and to H37Rv, we 
identified multiple genes that were differentially present or absent between H37Rv and L5 strains. Additionally, considerable 
gene content variability was found across L5 strains, including a split in the L5.3 sub- lineage into L5.3.1 and L5.3.2. These 
gene content differences had a small knock- on effect on transmission cluster estimation, with clustering rates influenced by 
the selected reference genome, and with potential overestimation of recent transmission when using H37Rv as the reference 
genome. We conclude that full capture of the gene diversity, especially high- resolution outbreak analysis, requires a variation of 
the single H37Rv- centric reference genome mapping approach currently used in most whole- genome sequencing data analy-
sis pipelines. Moreover, the high within- lineage gene content variability suggests that the pan- genome of M. tuberculosis is at 
least several kilobases larger than previously thought, implying that a concatenated or reference- free genome assembly (de 
novo) approach may be needed for particular questions.
DATA SUMMARY
Sequence data for the Illumina dataset are available at the 
European Nucleotide Archive (ENA; https://www. ebi. ac. 
uk/ ega/) under the study accession numbers PRJEB9003, 
PRJEB38656, PRJEB4884, PRJEB38317, PRJEB31139, 
PRJEB6273 and PRJEB31144. Individual run accession 
numbers are indicated in Table S8 (available in the online 




Sanoussi et al., Microbial Genomics 2021;7:000437
genome are available on the ENA accession SAME3170744. 
The assembled L5 Benin genome is available at the National 
Center for Biotechnology Information (NCBI) with accession 
PRJNA641267. The two other complete genomes of L5 strains 
from Gambia (PcbL5Gam, WBB1453_11-00429-1 [1]) and 
Nigeria (PcbL5Nig, WBB1454_IB091-1 [1]) can be found at 
http:// pathogenseq. lshtm. ac. uk/# tuberculosis (Tuberculosis 
section/Karonga Methylation study). To ensure that the 
naming conventions for the genes in the genomes of the three 
L5 strains can be followed, we have uploaded these annotated 
files to figshare [2].
The custom Python scripts used in this analysis can be found 
at https:// github. com/ conmeehan/ pathophy.
INTRODUCTION
Tuberculosis (TB) is caused by pathogenic bacteria of the 
Mycobacterium tuberculosis complex (MTBC) that consists 
of strains of nine human- adapted lineages and several 
animal- adapted lineages [3–6]. This group is highly clonal 
with no detected horizontal gene transfer [7, 8]. Strains of 
particular lineages are primarily defined by large sequence 
polymorphisms (LSPs, the presence or deletion of genomic 
regions) such as the TbD1 region (MTBC- specific deletion 
1) [9], other regions of difference (RDs) [10, 7, 11–13] and 
signature single- nucleotide polymorphisms (SNPs) [14]. 
RDs are particular long genomic regions deleted in some 
groups of MTBC strains but present in others; thus many 
MTBC lineages can be classified in groups using that LSP 
[10, 12, 13, 15]. Broadly, the lineages of the MTBC occur 
within three major clades: (1) L1–L4 and L7 form one group, 
(2) L5, L6, L9 and the animal lineages form another and (3) 
L8 sits within its own clade [4–6], based on the presence/
absence of specific RDs, especially TbD1 [12, 16, 17]. L5 and 
L6, also called M. tuberculosis var. africanum (or historically 
M. africanum West- african 1 and 2, respectively) [18, 19] are 
primarily restricted to West Africa, where they cause up to 
40 % of human TB [20, 21]. The reasons for the geographical 
restriction of L5 and L6 remain unclear, although adaptation 
to particular human subpopulations has been suggested [10, 
22–24].
Several phenotypic and genotypic features separate L5 and 
L6 strains from strains of the other human- adapted lineages. 
Some TB diagnostics have a lower performance for L5 and L6 
strains, compared to strains of other MTBC lineages [25, 26] 
and these lineages are less likely to grow in culture [27], with 
dysgonic appearance on solid medium [18, 26, 28, 29], despite 
the inclusion of pyruvate- supplemented medium [21, 27]. 
Mutations in genes essential for growth in culture were identi-
fied for L6 strains [30], yet for L5 strains the reasons for the 
difficulty in growth remain unclear. L6 strains and those of the 
closely related animal strains/lineages such as Mycobacterium 
bovis are reported to be less virulent in humans than those 
from other human- adapted MTBC lineages in population- 
based studies [20, 31, 32] and in genome studies of mutations 
in virulence regulation genes/systems [33, 34]. Infection with 
an L6 strain progresses slowly to TB disease, and is associated 
with impaired immunity in some settings but not all (e.g. 
HIV infection [20]). In contrast, although some authors have 
studied the genomics of L5 strains [35–37], protein secre-
tion and in vivo immunogenicity [35], much remains to be 
learned on the genomics, virulence and disease progression 
of L5 strains.
Whole- genome sequencing (WGS) based on next- generation 
sequencing (NGS) of MTBC strains often involves data 
analysis by mapping of short sequence reads of the strains 
to a complete reference genome [38], usually H37Rv [39, 40] 
or a reconstructed ancestor with the same gene content as 
H37Rv [22, 41, 42]. The resulting SNPs are then used for 
drug resistance determination, subtyping and transmission 
analyses [38]. However, since H37Rv is a L4 strain, it might 
not be representative for the genome of strains of other MTBC 
lineages. Thus, if H37Rv is used as basis for genome analysis, 
several genes or larger genomic regions may be missed, 
resulting in an underestimation of genome diversity among 
the strains of other lineages that may, however, provide addi-
tional information, e.g. for transmission analysis.
The members of the MTBC evolved from an environmental 
organism to an obligate pathogen through genome reduction 
and acquisition of new genes [43]. In addition, it is known 
that some differences in gene content exist between strains 
of different lineages [10, 38, 44–48]. Furthermore, it was 
reported that genes had a higher genetic diversity among 
Impact Statement
The Mycobacterium tuberculosis complex (MTBC) consists 
of nine human- associated lineages. Although many of 
these have been described for decades, little is known 
about the gene content variation both between and 
within strains of these lineages. This is most pronounced 
for strains of lineage 5 (L5), once part of the Mycobac-
terium africanum species. We compared the genomes of 
over 350 clinical L5 strains, the largest dataset gathered 
to date, to each other and the H37Rv reference strain to 
look for gene content variation and the potential impact 
this would have on clinical use of genome sequence data. 
We found that multiple genes are differentially present 
or absent between H37Rv and L5 strains, and that there 
is high within- L5 gene content variability, resulting in 
the split of the sub- lineage L5.3 into L5.3.1 and L5.3.2. 
We quantified the potential impact of this gene content 
difference on transmission clustering estimation. We 
found that the current H37Rv- centric approach widely 
used in MTBC epidemiology would overestimate the clus-
tering rate of L5 strains since it misses single- nucleotide 
polymorphisms present in L5- only genes. Thus, for high- 
resolution outbreak analysis, MTBC epidemiological 
studies may need to move away from the H37Rv- centric 
approach, especially when looking at transmission in 
countries where L5 is prominent.
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L6 strains compared to L5 ones [36], but the difference in 
gene content between strains of these two lineages was not 
investigated, but had been alluded to in an earlier abstract 
publication [37]. Further, little is known about the gene differ-
ences between genomes of L4 and L5 strains and the potential 
limitations this may impose for in- depth analysis of genome 
studies of L5 strains (e.g. sub- lineage detection and transmis-
sion tracking). Similarly, little is known about within- lineage 
diversity in terms of gene content.
To address these questions, we assessed the gene content 
diversity of L5 strains in the context of WGS and reference 
selection. To this end, we analysed 358 genomes of L5 strains, 
including 3 complete genomes, and compared them to H37Rv 
and strains of closely related lineages [L6 and M. tuberculosis 
var. bovis (hereafter called M. bovis) [19]. Our main focus 
was to determine particularities in the genomes of L5 strains 
compared to the MTBC strain type (H37Rv, a L4) and strains 
of MTBC lineages phylogenetically closely related to L5 (L6 
and M. bovis); deduce hypotheses for L5 phenotype/biology; 
and define the level of within- lineage gene content differences 
among strains of this lineage of the MTBC.
METHODS
Genomes
Complete genomes (PacBio-sequenced, complete long 
reads)
Three complete genomes from L5 clinical isolates, all 
sequenced with the PacBio SMRT technology, were analysed. 
One genome was from a Benin isolate [PcbL5Ben; sequenced 
in this study, National Center for Biotechnology Information 
(NCBI) accession PRJNA641267], one from an isolate from 
The Gambia (PcbL5Gam, WBB1453_11-00429-1) [1] and 
one from Nigeria (PcbL5Nig, WBB1454_IB091-1) [1]. These 
genomes also represent disparate parts of L5’s diversity, repre-
senting a broad range of L5 sub- lineages, as recently defined 
[6]. The previously published reference/complete genomes 
H37Rv (L4) (NC_000962.3) [39, 40, 49], L6 (GM041182, 
GenBank accession: FR878060.1, GCF_0001593225.1_
ASM159322v1) [50] and M. bovis (AF2122/97, accession: 
LT708304.1) [51] were also included.
Whole genomic DNA extraction
Genomic DNA extraction was performed on growth from 
fresh Löwenstein–Jensen slants using the semi- automated 
Maxwell 16 Cell DNA purification kit in the Maxwell 16 
machine, or from the late exponential phase of growth in 7H9 
medium, using the CTAB method [6, 52].
Assembly and annotation of the complete (PacBio-
sequenced) genomes
The Benin PacBio- sequenced genome was assembled using 
HGAP [53] and Quiver [53] and checked for sufficient quality 
and coverage (10 000 bp sliding window coverage was always 
above 65× and average coverage across entire genome was 
107×). The other two PacBio- sequenced genomes were 
already assembled as described previously [1]. The genome 
sequences of all three complete (PacBio- sequenced) genomes 
were annotated using Prokka-1.12 [54] based on the reference 
genome H37Rv annotation.
Gene presence–absence analysis
Gene content differences were assessed with an all- vs- all 
blastn approach, using blast+ version 2.8.1 [55, 56]. For a 
specific genome–genome comparison, the following proce-
dure was used: the gene sequences of genome 1 (ffn file; coding 
regions only) were compared to those of genome 2 using an e- 
value cut- off of 1e−05 and a minimum similarity of 70 % to look 
for any homology for each gene. Those genes found in genome 
1 and not in genome 2 were then compared to the complete 
(PacBio- sequenced) genome (fna file; coding and non- coding 
regions) of genome 2 to look for pseudogenes (herein quali-
fied as ‘suspected pseudogenes’) using blastn with the same 
cut- offs. These suspected pseudogenes were then confirmed 
using tblastn of the genome 1 protein sequences (faa file) 
compared to the complete (PacBio- sequenced) genome (fna 
file) of genome 2. This procedure was used to compare the 
complete (PacBio- sequenced) genomes of all three L5 strains 
to each other as well as each to H37Rv. Those genes present or 
absent in H37Rv (or pseudogenes in either) were compared in 
a similar manner to the L6 and M. bovis reference strains to 
determine whether these genes/pseudogenes are L5- specific 
(i.e. present in L5, but not in H37Rv, L6 and M. bovis).
The ffn files of H37Rv, the complete (PacBio- sequenced) 
genomes of the three L5 strains and the complete genome 
of the L6 reference strain were also aligned using progres-
siveMauve (v20150226) [57] to identify rearrangements and 
examine synteny.
L5 Illumina-sequenced (short reads) genomes
In total, whole genomes from 355 L5 strains from various 
countries sequenced on the Illumina platform were included 
in the study. These genomes were derived from a larger study 
on the genetic diversity of L5 and L6 [6]. After reducing 
isolate redundancy (i.e. 1 representative retained for those 
that were extremely closely related), genomes from 205 L5 
strains formed a non- redundant dataset. These 205 strains 
(genomes) originated from West, South, East and Central 
Africa (Table S8), but primarily (n=155) from two regions 
within West Africa: the western part of West Africa (including 
The Gambia, Sierra Leone, Ivory Coast, Liberia, Guinea and 
Mali) and the eastern part of West Africa (including Ghana, 
Benin and Nigeria) [6]. In general, L5 and L6 are geographi-
cally restricted to West and Central Africa, making this 
genome selection from L5 strains representative of most of 
the geographical regions affected.
Mapping of L5 Illumina reads to H37Rv and L5 complete 
(PacBio-sequenced) genomes
Raw reads (fastq files) of the 205 non- redundant Illumina- 
sequenced genomes were mapped respectively to H37Rv and 
each of the PacBio- sequenced genomes of the 3 L5 strains 
using the MTBseq pipeline [58]. The depth mapping coverage 
of the samples in the clinical Illumina- sequenced genomes 
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against the reference genomes (percentage read mapping, 
unambiguous coverage mean) was compared between the 
PacBio- sequenced genomes of the three L5 strains and 
between the PacBio- sequenced genome of each L5 strain 
and H37Rv. Mapping statistics parameters such as percentage 
unambiguous total base, uncovered bases, SNPs, deletions, 
insertions, substitutions and percentage genes mapped to 
reference were also compared using the PacBio- sequenced 
genome of each L5 strain or H37Rv as a reference.
Checking unique versus missing genes in Illumina-
sequenced genomes of L5 strains and SNPs in those 
confirmed as L5-specific
The genes found to be present or absent in L5 based on genome 
comparisons of the PacBio- sequenced genomes of the three 
L5 strains with H37Rv were checked for their expected pres-
ence or absence in the Illumina- sequenced genomes of L5 
strains. Using the position tables produced by the MTBseq 
pipeline, a gene was considered absent if 95 % of its position in 
the genome had fewer than eight reads covering them. From 
these data, a gene presence/absence matrix was generated 
for Illumina- sequenced genomes of L5 strains mapped to 
H37Rv and each of the three complete (PacBio- sequenced) 
genomes of L5 strains. Genes found to be L5- specific (present 
in complete PacBio- and Illumina- sequenced genomes) 
were also checked for SNPs in these genes using each of the 
complete (PacBio- sequenced) genomes of the three L5 strains 
as a reference. The script used for undertaking this analysis 
can be found at https:// github. com/ conmeehan/ pathophy.
Calculating the effect of reference genome selection on 
pairwise SNP distances
Transmission analysis of MTBC strains often involves 
clustering strains together based on specific SNP cut- offs 
[38, 59, 60]. We assessed whether the selection of the refer-
ence genome (H37Rv, PcbL5Ben, PcbL5Gam or PcbL5Nig) 
changed the clustering rate of L5 strains. For this we used the 
non- redundant set of L5 genomes from a previous study on 
L5 diversity [6], which included the 205 detailed above and 
a further 145 strains that were closely related to at least 1 of 
these 205 strains. Additionally, the TB- Profiler online SRA 
search tool (https:// tbdr. lshtm. ac. uk/ sra) was used to identify 
a further 5 isolates that were not in this dataset, resulting in 
355 strains being included in this clustering study.
SNP alignments of the Illumina- sequenced genomes were 
created by first mapping to each of the four reference genomes 
(H37Rv and three PcbL5). The Amend function of MTBseq 
does this automatically for H37Rv, including masking of 
repetitive regions, accounting for 10 % of the genome [40], and 
exclusion of columns with 95 % ambiguous calls. To under-
take this for the reference genomes from the three L5 strains, 
repetitive regions were first determined from the annotations 
of the genes. All genes whose description contained one of the 
following words was excluded: integrase, PE family, PE- PGRS, 
phage, transposase. SNP alignments were then created using 
MTBseq as done for H37Rv. Pairwise distance matrices, one 
for each alignment based on each reference genome, were 
created using a Python script that can be found at https:// 
github. com/ conmeehan/ pathophy. Loose transmission 
clusters were created from these matrices at a cut- off of 1, 5 
and 12 SNPs, as described previously [59]. Clustering rates 
and the presence of a strain in a transmission cluster was 
then compared across the four reference genome mapping 
approaches.
Determination of putative function of genes differentially 
present or absent in the complete (PacBio-sequenced) 
genomes of L5 strains
To find the (putative) function of genes present or absent only 
in L5 strains, and genes present in L5 strains but pseudogenes 
in H37Rv/L6/M. bovis or vice versa, the fasta sequences of the 
genes were searched against the NCBI’s NR database using 
blastx2.8.1+ [61] as well as the Tuberculist database (http:// 
tuberculist. epfl. ch), Mycobrowser (https:// mycobrowser. epfl. 
ch/) [62] and the literature. Furthermore, the gene function 
group/class was found using the COG database [63] and 
Mycobrowser.
Determination of the sub-lineage of the L5 strains
The sub- lineage of the strains was determined by looking 
for sub- lineage- defining SNPs in the genomes of L5 strains 
as previously described [6, 35]. The sub- lineage- defining 
SNPs were searched for in the SNP data generated using the 
MTBseq pipeline with H37Rv as the reference genome.
RESULTS
Comparative analysis of the complete (PacBio-
sequenced) genomes of L5 and other lineages 
strains reveals differences in gene content
The number of genes, including paralogues, in the complete 
L5 (PacBio- sequenced) genomes of the three L5 strains 
was: 4189 in the PcbL5Ben genome, 4162 in PcbL5Gam 
and 4134 in PcbL5Nig versus 4126 in H37Rv, 4126 in the 
reference L6 genome (GM041182) and 4059 in the refer-
ence M. bovis genome (AF2122/97). Hence, the maximum 
gene count difference was 55 genes among the 3 L5 strains 
from this study (4189–4134=55, including copies of genes 
with multiple copies), 63 genes among the human- adapted 
lineages (H37Rv, L5, L6; 4189–4126=63) and 130 genes 
among the human- and animal- adapted lineages (H37Rv, 
L5, L6 and M. bovis; 4189–4059=130).
The size of the complete genomes of L5 strains was respec-
tively 4 438 262 bp for PcbL5Ben, 4 424 447 for PcbL5Gam and 
4 417 534 for PcbL5Nig (data in Figshare [2]). The size was 
4 411 532 bp for H37Rv and 4 493 502 for the M. bovis reference 
genome (data from annotation with Prokka).
The visualization of the structure of the genomes showed that 
all three complete genomes of all L5 strains had a region that 
was absent in H37Rv. Furthermore, the PacBio- sequenced 
genome of the Nigerian L5 strain (PcbL5Nig) was missing an 
additional region (herein called L5Nig- Del) that was present 
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in the genomes of the Benin and the Gambian L5 strains and 
also present in H37Rv.
The genome of the Benin strain contained a syntenic block 
of three genes (1148, 1104, 2840 bp) that were present in 
neither the genome of the Nigerian strain nor the one of the 
Gambian strain (Tables 1 and 2). These increased the pange-
nome of L5 by at least 5092 bp. The Benin and Gambian 
strains each contained 33 genes that were not present in the 
Nigerian strain (Table 2 and S1). Interestingly, 32 of these 
genes were also present in H37Rv (Table 2 and S1). These 
32 genes were thus missing in the Nigerian L5 strain exclu-
sively, meaning that its ancestor has genes with a subsequent 
loss in the Nigerian L5 strain. Those 32 genes – absent in 
the Nigerian L5 strain only – were sequentially contiguous 
and formed 3 blocks of 19, 11 and 2 genes (Table S1). We 
found that 30 of those genes, the blocks of 19 and 11, were 
separated by 1 gene and represented the L5Nig- Del region 
(mentioned in the paragraph above, Table 3). Additionally, 
11 genes were shared by the 3 PacBio- sequenced genomes 
of L5 strains, which were absent in H37Rv (Table S2), while 
9 genes present in H37Rv were not present in any of the 3 
complete (PacBio- sequenced) genomes of L5 strains (Table 
S3). Two (Rv2073c, Rv2074) of those nine genes were only 
present in H37Rv but absent in the complete genomes of 
L5, L6 and M. bovis strains. Note that for the gene presence/
absence analysis, the genes are often referred to by the Rv 
designation but are actually putative orthologues of those 
H37Rv genes.
Six of the genes shared by the three complete (PacBio- 
sequenced) genomes of L5 strains were confirmed pseudo-
genes in H37Rv (Table S4). Three genes present in H37Rv 
were confirmed to be pseudogenes in the three complete 
(PacBio- sequenced) genomes of the L5 strains (Table S5).
Gene presence/absence and related SNPs in 
lineage-specific genes in a wider set of clinical 
strains
The mapping estimates of the Illumina- sequenced genomes 
are presented in Table 4. Three (ERR502505, ERR751302, 
ERR1215478) of the 205 Illumina- sequenced genomes were 
identified as mixed infection strains based on their MTBseq 
output, and thus excluded from the analysis. Mapping 
quality and coverage against a complete L5 reference was 
superior to the H37Rv reference approach (Table  3, Fig. 
S1), as expected. Using the complete (PacBio- sequenced) 
genomes from Benin and The Gambia strains, yielded 
similar mapping estimates that were better than those of 
the genome of the Nigerian L5 strain, likely due to the large 
deletion in this genome. The genes specific to PcbL5Ben 
[3, region PcbL5Ben_1893 through PcbL5Ben_1895; none 
specific to PcbL5Gam (0), PcbL5Nig (0)] were each found 
in 77.7 % (157/202, Table 1) of the 202 Illumina- sequenced 
genomes of L5 strains.
Interestingly, 3 % of the Illumina- sequenced genomes of 
L5 strains (6/202) had similar patterns of large gene loss 
Table 1. Presence in Illumina- sequenced genomes from 202 L5 strains of genes detected in only 1 of the complete genomes of the 3 L5 strains from 
Benin, The Gambia and Nigeria
Gene Co- ordinates in the specified genome Functional group Present in L5 Illumina- sequenced 
genomes
% (n=202)
PcbL5Ben PcbL5_01893 2004773–2005918 Cell wall and cell processes 77.7 (157)
  PcbL5_01894 2006144–2007247 Intermediary metabolism and respiration 77.7 (157)
  PcbL5_01895 2007448–2010285 Cell wall and cell processes 77.7 (157)
Table 2. Gene content difference between the M. tuberculosis H37Rv (L4) genome and the complete (PacBio- sequenced) genomes of three L5 strains 
from Benin, The Gambia and Nigeria
Present in
  PcbL5Ben PcbL5Gam PcbL5Nig H37Rv
Absent in PcbL5Ben 9†
PcbL5Gam 2+3* 2+9†
PcbL5Nig 34+3* 34 32+9†
H37Rv 10‡+3* 10‡ 10‡
    4189 4162 4134 4126
*, includes three genes only present in PcbL5Ben.
†, includes nine genes only present in H37Rv.
‡, includes 10 genes shared by the PcbL5 (Benin, The Gambia, Nigeria) and absent in H37Rv.
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Table 3. Genes in the L5.3.2- Del region (PcbL5Nig- Del) and their function category. None of the 30 genes is an essential gene (Mycobrowser). The 30 
genes formed 2 regions: Rv1493 through Rv1509 (L5.3.2- Del region 1) and Rv1511 through Rv1521 (L5.3.2- Del region 2), separated by the gene Rv1510, 
which is present in the L5.3.2 isolate. All genes in the table are absent from all L5.3.2 genomes (both PacBio- and Illumina- sequenced), except those 
marked with an asterisk (*), which are present in the PacBio- sequenced genome (PcbL5Nig) but absent in all six Illumina- sequenced genomes, and the 
one marked with a hash (#) (Rv1492), which is a gene present in all L5.3.2 strains and flanking the L5.3.2- specific deletion
Gene name Size Co- ordinates in H37Rv Functional category Present in L5 Illumina- sequenced genomes
% (n=202)
Rv1492# (mutA) 1848 bp 1 682 157–1 684 004 Lipid metabolism 100 (202)
Rv1493 (mutB) 2253 bp 1 684 005–1 686 257 Lipid metabolism 97 (196)
Rv1494 (mazE4) 303 bp 1 686 271–1 686 573 Virulence, detoxification, adaptation 97 (196)
Rv1495 (mazF4) 318 bp 1 686 570–1 686 887 Virulence, detoxification, adaptation 97 (196)
Rv1496 1005 bp 1 686 884–1 687 888 Cell wall and cell processes 97 (196)
Rv1497 (lipL) 1290 bp 1 687 941–1 689 230 Intermediary metabolism and respiration 97 (196)
Rv1498c 618 bp 1 6893 03–1 689 920 Intermediary metabolism and respiration 97 (196)
Rv1498A 213 bp 1 690 134–1 690 346 Conserved hypothetical protein 97 (196)
Rv1499 399 bp 16 900 407–1 690 805 Conserved hypothetical protein 97 (196)
Rv1500 1029 bp 1 690 850–1 691 878 Intermediary metabolism and respiration 97 (196)
Rv1501 822 bp 1 691 890–1 692 711 Conserved hypothetical protein 97 (196)
Rv1502 900 bp 1 692 924–1 693 823 Unknown 97 (196)
Rv1503c 549 bp 1 693 996–1 694 544 Conserved hypothetical protein 97 (196)
Rv1504c 600 bp 1 694 545–1 695 144 Conserved hypothetical protein 97 (196)
Rv1505c 666 bp 1 695 281–1 695 946 Conserved hypotheticals 97 (196)
Rv1506c 501 bp 1 695 943–1 696 443 Unknown 97 (196)
Rv1507A 504 bp 1 697 356–1 697 859 Unknown 97 (196)
Rv1507c 696 bp 1 696 727–1 697 422 Conserved hypotheticals 97 (196)
Rv1508c 1800 bp 1 698 095–1 699 894 Cell wall and cell processes 97 (196)
Rv1508A 636 bp 1 699 866–1 700 228 Conserved hypotheticals 97 (196)
Rv1509 882 bp 1 700 212–1 701 093 Unknown 97 (196)
Rv1510 * 1299 bp 1 701 295–1 702 593 Cell wall and cell processes 97 (196)
Rv1511 (gmdA) 1023 bp 1 703 074–1 704 096 Intermediary metabolism and respiration 97 (196)
Rv1512 (epiA) 969 bp 1 704 093–1 705 061 Intermediary metabolism and respiration 97 (196)
Rv1513 732 bp 1 705 058–1 705 789 Conserved hypothetical protein 97 (196)
Rv1514c 789 bp 1 705 807–1 706 595 Conserved hypothetical protein 97 (196)
Rv1515c 897 bp 1 706 630–1 707 526 Conserved hypothetical protein 97 (196)
Rv1516c 1011 bp 1 707 529–1 708 539 Intermediary metabolism and respiration 97 (196)
Rv1517 765 bp 1 708 871–1 709 635 Cell wall and cell processes 97 (196)
Rv1518 960 bp 1 709 644–1 710 603 Conserved hypothetical protein 97 (196)
Rv1519 270 bp 1 710 733–1 711 002 Conserved hypothetical protein 97 (196)
Rv1520 1041 bp 1 711 028–1 712 068 Intermediary metabolism and respiration 97 (196)
Rv1521 (fadD25) 1752 bp 1 712 302–1 714 053 Lipid metabolism 97 (196)
Rv1522c* 
(mmpL12)
3441 bp 1 714 172–1 717 612 Cell wall and cell processes 97 (196)
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like the Nigerian complete (PacBio- sequenced) genome, 
as they missed 30 of the 32 genes present in the genomes 
of the Benin and Gambian strains and H37Rv. These six 
PcbL5Nig- like Illumina- sequenced genomes of L5 strains 
formed a monophyletic group within the L5 clade (Fig. 1), 
suggesting a single loss of these gene clusters, although 
those six L5 strains genomes originated from several 
different countries, including Benin, Ghana and Nigeria. 
The 2 blocks of 19 (15 984 bp, Rv1493 through Rv1509) and 
11 genes (10 209 bp, Rv1511 through Rv1521), separated by 
1 gene (3441 bp, Rv1510), amounted in total to 26 193 bp. 
The two blocks contain genes whose annotations include 
mutB, mazE4, mazF4 and others with various putative func-
tions (Table 3, Table S6); none of them were essential genes 
(Mycobrowser).
Four of the 11 genes present in the 3 complete (PacBio- 
sequenced) genomes of the L5 strains but absent in H37Rv 
were found in all 202 Illumina- sequenced genomes of the 
L5 strains (Table 5), while the others were found in variable 
amounts [80.2–98 % (162–198)] (Table S2). These four genes 
include: Mb2048c (of unknown function, belonging to the 
RvD1 deletion in H37Rv), a PE/PPE gene, a hypothetical 
protein (possibly an IS256 transposase) and a hypothetical 
protein possibly related to the CAAX conserved domain 
(Table  5). Two of these four genes were only present in 
L5 genomes (a PE/PPE gene and a hypothetical protein, 
possibly CAAX conserved domain), while the remaining 
two [Mb2048c (RvD1) and hypothetical protein, possibly 
IS256 transposase] were found in L6 and M. bovis as well 
(Tables 5 and S2). Importantly for phylogenetic purposes, 
SNPs were detected in all 4 genes in 1.5–3.5 % of the 202 
Illumina- sequenced genomes of L5 strains (Table S2). 
Predicted functions for all L5- specific genes are listed in 
Table S2.
Six (Rv1977, Rv1979c, Rv1993c, Rv1995, Rv2073c, Rv2074) 
of the 9 genes that were present in H37Rv and absent in 
the 3 complete (PacBio- sequenced) genomes of L5 strains 
were absent in all 202 Illumina- sequenced genomes of 
L5 strains (Table 5 and S3). Rv1977 is a conserved hypo-
thetical, probably a peptidase; Rv1979c is involved in ‘cell 
wall and cell processes’, probably a permease; Rv1993c 
and Rv1995 are conserved hypotheticals; and Rv2073c 
and Rv2074 are involved in ‘intermediary metabolism 
and respiration’, with Rv2073c probably a dehydrogenase 
and Rv2074 a pyridoxamine-5- phosphate oxidase (Myco-
browser, Table 5). Four of these genes (Rv1977, Rv1979c, 
Rv1993c, Rv1995) were absent (did not have orthologues) 
in L5 strains only (i.e. present in L6 and M. bovis refer-
ence genomes), while the other two (Rv2073c and Rv2074) 
were also absent in L6 and M. bovis (Table 5). The three 
other genes absent from the complete (PacBio- sequenced) 
genomes were present in a minority of the L5 Illumina- 
sequenced genomes (Table S3, Fig. S1). Predicted functions 
for all nine genes are listed in Table S3.
Table 4. Mapping of Illumina- sequenced genomes of the 202 L5 strains to the M. tuberculosis H37Rv (L4) genome and complete genomes of 3 L5 
strains from Benin, The Gambia and Nigeria (mapping statistics/estimates). The best mapping results (numbers) are written in bold. When the best 
mapping result has been obtained for PcbL5Nig as the reference, the next best result is also written in bold (as PcbL5Nig compared to the other 2 
PcbL5 genomes missed a 30- gene region)
H37Rv PcbL5Ben PcbL5Gam PcbL5Nig
Reads
Mean of percentage L5 reads mapped to 96.9 97.5 97.3 96.5
Mean of unambiguous coverage mean 122.3 123.2 123.3 123.0
Bases
Mean of percentage unambiguous total bases 98.0 98.8 98.9 98.2
Mean uncovered 30 599.0 18 916.7 14 766.4 35 340.4
Mean SNP 2209.7 529.5 513.0 503.3
Mean deletions 374.1 96.5 96.4 97.9
Mean insertions 239.5 77.0 107.6 60.8
Mean substitutions (including stop codons) 1193 0 0 0
Genes
Mean of percentage gene mapped (presence) 99.59 99.71 99.79 99.76
L5 illumina having all the ref. genome genes, % 
(n=202)
0 2 (4) 7.4 (15) 0
Mean gene count difference between L5 
Illumina- sequenced genomes (gene count per 
Illumina- sequenced genome minus minimum 
gene count)
30.3 38.2 34.4 32.8
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Sub-lineage of the strains (PacBio and Illumina-
sequenced genomes)
The determination of the strains sub- lineage revealed that the 
PcbL5Ben strain is an L5.3 strain that contains the 30 genes 
(2 blocks of 19 and 11 genes: Rv1493 through Rv1509 and 
Rv1511 through Rv1521), whereas the PcbL5Nig strain is also 
a L5.3 strain, but placed in a different clade (Fig. 1). Based on 
this new RD (L5Nig- Del), we classified PcbL5Ben as a L5.3.1 
strain, the PcbL5Nig as a L5.3.2 strain. The PcbL5Gam strain 
is a L5.1.5 strain. The distribution of the Illumina- sequenced 
genomes is outlined in Table S7, amounting to a total of 
146 L5.1 strains (72.3 %); 13 (6.4 %) L5.2 strains; 14 L5.3 strains 
(6.9 %); and 29 (14.4 %) strains of unknown (potentially new) 
sub- lineages.
Impact of the reference genome selection on 
genetic distances used for transmission clustering 
rates
Transmission analysis was undertaken on an expanded set 
of 352 L5 strains using each of the four reference genomes 
(H37Rv, PcbL5Ben, PcbL5Gam and PcbL5Nig) for the SNP 
mapping. The current gold standard is to use the H37Rv 
genome (NC_000962.3) for calling SNPs and then creating 
transmission clusters at a specific SNP cut- off differentiating 
two and more strains. For this dataset, using a 12 SNP cut- 
off, it was found that 40.6 % (n=144) of strains were within a 
transmission cluster with at least 1 other isolate (Table 6), for 
a total of 55 clusters. Using the PcbL5Ben genome instead of 
the H37Rv genome as the reference reduced the number of 
clusters to 54, resulting in a clustering rate of 39.7 % at a 12 
SNP cut- off (Table 6). A similar reduction in transmission 
clustering was observed when using the PcbL5Nig genome 
as a reference but not when using the PcbL5Gam (Table 6). 
When a more conservative SNP cut- off was used, such as 
one SNP or five SNPs, the reduction in transmission clus-
tering rates was more pronounced and was observed for all 
the PcbL5 genomes (Table 6). This demonstrates that even 
with this small dataset, transmission cluster estimations are 
affected by the selection of the reference genome, with poten-
tial overestimation of recent transmission when using H37Rv 
as the reference genome.
DISCUSSION
Comparison of complete (PacBio- sequenced) genomes and 
Illumina- sequenced genomes from clinical strains revealed 
gene content diversity both within L5 strains and between L5 
strains and strains of other lineages. This diversity also had an 
impact on clinical epidemiology analysis of L5 strains, with 
Fig. 1. Phylogenetic tree showing the Illumina- sequenced genomes of the six L5 strains (L5.3.2) similar to the complete (PacBio- 
sequenced) genome of the Nigerian L5 strain (PcbL5Nig) and the position of the other two PacBio- sequenced L5 genomes (PcbL5Ben 
and PcbL5Gam). NigDel=L5Nig- Del=L5.3.2- Del=region of 30 genes (2 blocks of 19 and 11 genes: Rv1493 through Rv1509 and Rv1511 
through Rv1521) missing in L5.3.2 strains but present in all other L5 strains (L5.1, L5.2, L5.3.1 and new sub- lineages).
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the choice of reference genome affecting the estimation of 
recent transmission.
Several genes were found to be absent from the genome of 
either L5 strains only or also from strains of the closely related 
lineages L6 and M. bovis. Most of these genes are located 
within RDs previously described as being absent in one or 
all of these lineages.
RD9, consisting of Rv2073c and Rv2074 and partial Rv2072 
and Rv2075c [13], has previously been reported to be 
absent in L5, L6 and M. bovis [10, 12, 15]. In this study, we 
confirmed that Rv2073c and Rv2074 are absent in strains of 
these lineages. Rv2072 and Rv2075c were present in their 
truncated form in the genomes of all L5 strains as previously 
described [13]. Rv2073c is an NAD(P)- dependent oxidore-
ductase (NCBI) that catalyzes a wide range of reactions and 
is involved in redox sensor mechanisms [64, 65]. Rv2074 was 
previously thought to be a pyridoxine (vitamin B6) oxidase, 
but is now known to be a F420- dependent biliverdin reduc-
tase, a cofactor of vitamin B6 synthesis [66, 67]. Vitamin B6 
is essential for the survival and virulence of M. tuberculosis 










































































































































































































































































Table 6. Comparison of transmission clustering rates based on choice 
of reference genome. Short- read data from 355 L5 strains were 
mapped against each of the 4 reference genomes for SNP calling. 
Distance matrices between all strains were constructed per the 
reference approach and transmission clusters were defined based on 
specific SNP cut- offs
1 SNP





H37Rv 100 28.17 44
PcbL5Ben 94 26.48 43
PcbL5Gam 95 26.76 43
PcbL5Nig 95 26.76 43
5 SNP





H37Rv 129 36.34 53
PcbL5Ben 124 34.93 51
PcbL5Gam 124 34.93 51
PcbL5Nig 124 34.93 51
12 SNP





H37Rv 144 40.56 55
PcbL5Ben 141 39.72 54
PcbL5Gam 144 40.56 55
PcbL5Nig 141 39.72 54
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implicated in immune- evasive mechanisms to allow bacterial 
persistence [66, 67] (Table S3). Recently, it has been reported 
that the synthesis of F420 might be stimulated by phospho-
enolpyruvate [69], which is the precursor to pyruvate, a 
supplement often added to culture medium to improve the 
in vitro growth of L5, L6 and M. bovis strains. Furthermore, 
there is a suggestion that F420 is needed for the activation of 
the antituberculosis drugs pretomanid and delamanid [69].
Another gene absent in L5 strains is Rv1977. This gene is one 
of the 14 genes contained in RD7 [13]), which is known to 
be lacking completely from strains of L6 and animal- adapted 
lineages such as M. bovis [12]. Similarly, Rv1979c, 1 of 10 
genes that make up RD2, was absent from genomes of L5 
strains; this RD is also absent from late- generation M. bovis 
BCG such as M. bovis BCG Pasteur strains [12]. Rv1978, 
another of the 10 genes in RD2, and located in the region 
Rv1977- Rv1978- Rv1979c was absent in the 3 complete 
(PacBio- sequenced) genomes of L5 strains, but present in 2 
L5 strains Illumina- sequenced genomes [2/202, 1 %; further 
confirmed using blast search and manual check of the gene 
in the reads of the 2 L5 strains genomes (ERR439931 and 
ERR4192386)], making up the region containing Rv1977, 
Rv1978 and Rv1979c, a region absent in most of L5 strains 
(99 %, 200/202). Rv1979c has been associated with clofazimine 
and bedaquiline resistance [70, 71], two of the drugs used 
for the treatment of rifampicin- and multidrug- resistant TB 
[72, 73], but minimal inhibitory concentration testing of 
clofazimine in five L5 strains did not find that the deletion 
conferred resistance [74]. Further studies and protein func-
tion discovery is needed to investigate the consequences of 
the absence of those genes in genomes of L5 strains. Rv1978 
is required for bacterial survival in macrophages [75].
Rv1993c and Rv1995 were absent in all L5 genomes. Rv1994c 
a gene outside of known RDs, located in the region Rv1993c- 
Rv1994- Rv1994 was absent in the three complete (PacBio- 
sequenced) genomes of L5 strains, yet present in one L5 strain 
Illumina- sequenced genome [1/202, 0.5 %; further confirmed, 
using blast search and manual checking of Rv1994 in the 
reads of the concerned L5 strain genome (ERR439931)]. This 
resulted in the absence, in most of the L5 strains (99.5 %, 
201/202) of the region containing Rv1993c, Rv1994c and 
Rv1995. Rv1994c is involved in the regulation and transport 
(efflux) of toxic metals, especially copper, which is toxic in 
excess and may hamper in vitro growth [76–80] (Table S3). 
Rv1993c forms with Rv1994 (cmtR) the operon cmtR- Rv1993c- 
ctpG, and Rv1995 is involved in oxygen transport (Table S3).
In combination, the absence of these genes in L5 strains 
suggests that they would be less likely to survive in 
macrophages (Rv1978), have reduced growth in vitro (Rv1994c, 
as previously found by [27]), and be less immune- evasive, 
less persistent and less virulent (Rv2074) than L4 strains (at 
least H37Rv), as previously suggested for L5 and L6 strains 
[5, 32]). In addition, the absence of Rv2074 in most L5 strains 
(and in the complete genomes of L6 and M. bovis as well) 
suggests that L6 and M. bovis strains would also be less likely 
to be immune- evasive, to be persistent and to survive than 
L4 strains. Despite the presence of vitamin B6 in boiled egg 
(thus Lowenstein–Jensen medium), the quantity of vitamin 
B6 in the Lowenstein–Jensen medium is probably insufficient 
to allow a high yield of growth of L5, L6 and M. bovis strains 
in culture (survival). Further studies, including vitamin B6 
supplementation, could investigate the consequences of the 
absence of those genes in L5 strains (and L6 and M. bovis for 
Rv2074).
In contrast to the absence of some genes in RD2 and RD7, 
or all genes in RD9, RD5 was found to be present in its 
entirety in nearly all sequenced genomes of L5 strains. Some 
authors reported that up to 45 % of L5 strains missed RD5, 
while others reported that RD5 is present in most L5 strains 
[35, 81]. The RD5 region includes Rv2346 (truncated), 
Rv2347, Rv2348, Rv2349c (plcC), Rv2350c (plcB), Rv2351c 
(plcA) and a PPE gene [13]. Our findings showed that of the 
202 Illumina- sequenced L5 strains, the majority (196, 97 %) 
had the RD5 region in its entirety, whereas 6 L5 strains (3 %) 
missed a part (one or 2 genes among the non- PPE genes) of 
the RD5 region. Likewise, in contrast to a previous report 
[10], our data did not confirm that all L5 strains lack RD711 
(coordinates: 1 501 713–1 503 655 in H37Rv [82]) composed of 
Rv1333 (truncated), Rv1334, Rv1335 and Rv1336 (truncated). 
The lacking of RD711 was rather observed in all L5.1 strains 
in our dataset, which is in agreement with the report of Ates et 
al. [35] and also observed among 58.6 %(17/29) of L5 strains 
of unknown sub- lineages (Table S7).
We found that four genes, present in all of the L5 strains in 
our multi- country collection, were absent (no orthologues) 
in the H37Rv genome. Those genes represent 2382 bp, which 
is around 0.05 % of the total length (base pair) of a typical 
genome of an MTBC strain. Our findings are in line with 
those of other reports indicating that some genes present in 
genomes of clinical MTBC strains were absent (no ortho-
logues) in the H37Rv genome [46, 47]. Although these gene 
differences are small, they did affect the distance matrices 
used for transmission clustering analyses (Table 6). Overall, 
H37Rv- based mapping was found to place a slightly higher 
percentage of strains in transmission clusters than any 
L5- based mapping approach, especially at lower SNP cut- 
offs. This has implications for molecular epidemiology in 
West Africa, where most L5 strains are found. Additionally, 
if similar scenarios exist for other lineages, this may result in 
changes to all non- L4 transmission analyses.
Our findings support past recommendations to use additional 
reference genomes that are different from H37Rv [46, 83, 84]. 
Although another study [85] concluded that there is no need 
to use a lineage- specific reference genome, their observa-
tion was only based on the analysis of L4 clinical strains and 
focused on SNPs and short indels, not larger gene deletions or 
SNPs within these regions. In contrast, our findings indicate 
that mapping of NGS data from L5 strains to L4 reference will 
have an impact in terms of both reference genome coverage 
and coverage of lineage- specific genes.
While the use of a single L5 genome as reference would have 
many benefits over H37Rv for particular study questions, 
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several gene content differences were still observed within 
the L5 lineage. One (PcbL5Ben) of the three genomes of L5 
strains sequenced with PacBio had genes that were not shared 
with the two others that were all found in Illumina- sequenced 
genomes of L5 strains (thus excluding exogenous contamina-
tion) (Table 1). The L5NigDel was also found in the genomes 
of six L5 strains from different countries. These six strains 
formed a monophyletic group of the (SNP- defined) L5.3 sub- 
lineage [6] (Fig. 1), suggesting that the loss of these 30 genes 
is a marker for strains of L5.3.2 sub- lineage, compared to the 
sub- lineage L5.3.1 strains that have these genes intact. Indeed, 
deletions, as described for MTBC lineages [10, 45, 48], may 
also be limited to sub- lineages.
The between- and within- lineage differences in both gene 
content and potential functionality indicate a need for more 
closed genomes of MTBC sub- lineages to be constructed. 
Due to the impact of reference choice on transmis-
sion studies, there is now a need for varying approaches 
to NGS data analysis to be considered. For instance, 
sub- lineage- specific reference genomes could improve 
resolution, although such ad hoc (e.g. outbreak- specific) 
reference genomes are only specific to that particular situ-
ation/outbreak/population/lineage and cannot be used in 
another context, making comparisons between lineages 
and settings difficult. Alternatively, a pangenome- based 
reference genome(s) capturing all the known diversity may 
be required instead. This can take two forms: a composite 
genome containing all the genes found in strains of all 
lineages and sub- lineages of the MTBC (i.e. both the core 
and accessory genome) [86], represented as a graph instead 
of a single sequence [87–92], or a selection of reference 
genomes, with mapping to all or a subset undertaken, as 
has been done with strains of Mycobacterium chimaera and 
other pathogens [93, 94]. Other authors have also reported 
that, because of the genetic variability between strains, 
using a single strain genome as reference genome lacks 
accuracy [95–97]. This MTBC- wide pangenome approach 
has been suggested before, including for other organisms 
[38, 47, 95–100]. However, such an approach also has its 
own drawbacks, including difficulty in mapping reads that 
bridge the boundaries between accessory genes and the 
rest of the genome, comparing strains of different lineages 
including phylogenetic analyses and retention of gene 
names and codes in clinical use, where H37Rv is deeply 
embedded [89]. The specific sequence of each orthologue 
gene would also need to be chosen for such a reference, with 
the inferred ancestral genome representative of MTBC line-
ages approach being the most likely method [22, 42, 101].
Another alternative approach is a de novo assembly reference- 
free approach [38, 96, 102, 103], where strains are either 
assembled into contigs without the use of a reference genome 
or compared to each other without first calling SNPs. This 
would allow for clustering of samples regardless of lineage, 
e.g. for genotyping or transmission analyses using Mash (soft-
ware for fast/meta -genome distance estimation technique) 
[104] but would require new cut- offs for defining clusters 
and many additional steps for further gene annotation and 
between- sample comparisons, making its clinical use poten-
tially confusing.
A limitation of this study is that the complete (PacBio) and 
short- read (Illumina) genomes were derived from positive 
cultures, excluding possible minority L5 strain diversity, as 
L5 strains are overrepresented in negative cultures [27]. WGS 
applied directly to sputum is increasingly needed, especially 
for ancestral lineages (including L5 and L6), where negative 
culture or dysgonic isolates are more common and are a 
challenge for DNA extraction [26, 27]. There is also a limi-
tation regarding the comparison of gene presence/absence 
in strains of L5 versus L4 (including H37Rv), L6, M. bovis 
complete genomes; which is that our study only included a 
single complete genome of one strain of L4, L6 and M. bovis, 
respectively, while strains of these lineages may display 
similar variability to the intra- L5 variability we observed in 
our study. Of note, the genes that are present in L5 strains 
but not specific to L5 strains could be either active or inactive 
(mutated), requiring additional in vitro or in vivo validations 
to fully elucidate the metabolic profile of these strains.
In conclusion, the use of a (sub- )lineage reference genome 
can increase resolution for strain comparison in comparison 
to a H37Rv- based mapping approach for L5 genome analyses 
for epidemiology (transmission), phylogeny and sub- lineage 
determination. Still, the use of a (sub- )lineage reference 
genome may miss some within- lineage gene differences. 
For drug resistance detection in clinical L5 strains or strains 
of other lineages, H37Rv could still be used as a reference 
genome as resistance- related mutations are usually among 
the core genes (shared across all lineages). The high within- 
lineage gene content variability suggests that the pangenome 
of MTBC strains may be larger (at least by 5092 bp) than 
previously thought, implying that a reference- free genome 
assembly (de novo assembly) approach may be needed.
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